Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines
Tapinator, Inc.
1776 Broadway, Suite 1902, New York, NY 10019
_______________________________
(914) 930-6232
www.tapinator.com
investor.relations@tapinator.com
SIC Code: 7372 (Prepackaged Software)
AnnualReport
For the Period Ending: 12/31/2021
(the "Reporting Period")
As of 3/10/2022, the number of shares outstanding of our Common Stock was: 564,962
As of 12/31/2021, the number of shares outstanding of our Common Stock was: 564,962
As of 12/31/2021, the number of shares outstanding of our Common Stock was: 564,962
Indicate by check mark whether the company is a shell company (as defined in Rule 405 of the Securities Act of 1933 and Rule 12b-2 of the Exchange Act of 1934):
Yes: ☐ No: ☒
Indicate by check mark whether the company's shell status has changed since the previous reporting period:
Yes: ☐ No: ☒
Indicate by check mark whether a Change in Control1 of the company has occurred over this reporting period:
- "Change in Control" shall mean any events resulting in:
- Any "person" (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becoming the "beneficial owner" (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company's then outstanding voting securities;
- The consummation of the sale or disposition by the Company of all or substantially all of the Company's assets;
- A change in the composition of the Board occurring within a two (2)-year period, as a result of which fewer than a majority of the directors are directors immediately prior to such change; or
- The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the
OTC Markets Group Inc. | |
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021) | Page 1 of 12 |
Yes: ☐ | No: ☒ |
- Name and address(es) of the issuer and its predecessors (if any)
In answering this item, provide the current name of the issuer any names used by predecessor entities, along with the dates of the name changes.
Tapinator, Inc.
Formerly=Evolution Resources, Inc. until 11-2013
Formerly=BBN Global Consulting, Inc. until 7-2009
The state of incorporation or registration of the issuer and of each of its predecessors (if any) during the past five years; Please also include the issuer's current standing in its state of incorporation (e.g. active, default, inactive):
12/09/2013, Delaware; Active
Describe any trading suspension orders issued by the SEC concerning the issuer or its predecessors since inception:
None
List any stock split, stock dividend, recapitalization, merger, acquisition, spin-off, or reorganization either currently anticipated or that occurred within the past 12 months:
The issuer's Board of Directors has approved a stock dividend such that each stockholder will receive a dividend of four additional shares of common stock for each then-held share. As required, the issuer has submitted the stock dividend for approval to FINRA. If FINRA approves the stock dividend, the issuer will publicly announce the timing and other matters relating to the stock dividend. There can be no guaranty that FINRA will approve the stock dividend.
The address(es) of the issuer's principal executive office:
1776 Broadway, Suite 2002, New York, NY 10019
The address(es) of the issuer's principal place of business:
Check box if principal executive office and principal place of business are the same address: ☒
Has the issuer or any of its predecessors been in bankruptcy, receivership, or any similar proceeding in the past five years?
Yes: ☐ | No: ☒ |
If this issuer or any of its predecessors have been the subject of such proceedings, please provide additional details in the space below:
Not applicable
surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.
OTC Markets Group Inc. | |
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021) | Page 2 of 12 |
2) | Security Information | ||
Trading symbol: | TAPM | ||
Exact title and class of securities outstanding: | Common Stock | ||
CUSIP: | 876037 201 | ||
Par or stated value: | $0.001 | ||
Total shares authorized: | 25,000,000 | as of date: 12/31/2021 | |
Total shares outstanding: | 564,962 | as of date: 12/31/2021 | |
Number of shares in the Public Float2: | 396,196 | as of date: 03/07/2022 | |
Total number of shareholders of record: | 122 | as of date: 12/31/2021 |
All additional class(es) of publicly traded securities (if any):
Trading symbol: | |||||
Exact title and class of securities outstanding: | |||||
CUSIP: | |||||
Par or stated value: | |||||
Total shares authorized: | as of date: | ||||
Total shares outstanding: | as of date: | ||||
Transfer Agent | |||||
Name: | Continental Stock Transfer & Trust | ||||
Phone: | (800) 509-5586 | ||||
Email: | cstmail@continentalstock.com | ||||
Address: 1 State St., 30th Fl., New York, NY 10004 | |||||
Is the Transfer Agent registered under the Exchange Act?3 Yes: ☒ | No: ☐ |
- Issuance History
The goal of this section is to provide disclosure with respect to each event that resulted in any direct changes to the total shares outstanding of any class of the issuer's securities in the past two completed fiscal years and any subsequent interim period.
Disclosure under this item shall include, in chronological order, all offerings and issuances of securities, including debt convertible into equity securities, whether private or public, and all shares, or any other securities or options to acquire such securities, issued for services. Using the tabular format below, please describe these events.
A. Changes to the Number of Outstanding Shares
Check this box to indicate there were no changes to the number of outstanding shares within the past two completed fiscal years and any subsequent periods: ☐
- "Public Float" shall mean the total number of unrestricted shares not held directly or indirectly by an officer, director, any person who is the beneficial owner of more than 10 percent of the total shares outstanding (a "control person"), or any affiliates thereof, or any immediate family members of officers, directors and control persons.
- To be included in the Pink Current Information tier, the transfer agent must be registered under the Exchange Act.
OTC Markets Group Inc. | |
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021) | Page 3 of 12 |
Shares Outstanding as of Second Most Recent | |
Fiscal Year End: | *Right-click the rows below and select "Insert" to add rows as needed. |
Opening Balance |
Date 12/31/19 | Common: 549,958 | |||||||||
Preferred: 0 | ||||||||||
Date of | Transaction | Number of | Class of | Value of | Were the | Individual/ Entity | Reason for share | Restricted or | Exemption | |
Transaction | type (e.g. new | Shares | Securities | shares | shares | Shares were | issuance (e.g. for | Unrestricted | or | |
issuance, | Issued (or | issued | issued at | issued to | cash or debt | as of this | Registration | |||
cancellation, | cancelled) | ($/per | a discount | (entities must | conversion) | filing. | Type. | |||
shares | share) at | to market | have individual | -OR- | ||||||
returned to | Issuance | price at | with voting / | Nature of | ||||||
treasury) | the time | investment | Services | |||||||
of | control | Provided | ||||||||
issuance? | disclosed). | |||||||||
(Yes/No) | ||||||||||
10/29/2021 | New | 521 | Commo | $25.00 | No | IMS Group / | Warrant | Unrestrict | Section 4 | |
Issuance | n | Maria | Exercise | ed | (a) (1) | |||||
Hernandez | ||||||||||
10/28/2021 | New | 123 | Commo | $25.00 | No | Gonzalo E. | Warrant | Unrestrict | Section 4 | |
Issuance | n | Cortes | Exercise | ed | (a) (1) | |||||
10/28/2021 | New | 123 | Commo | $25.00 | No | David A. | Warrant | Unrestrict | Section 4 | |
Issuance | n | Johnson | Exercise | ed | (a) (1) | |||||
10/28/2021 | New | 123 | Commo | $25.00 | No | Gothamm | Warrant | Unrestrict | Section 4 | |
Issuance | n | Corporation / | Exercise | ed | (a) (1) | |||||
Nelson | ||||||||||
Rodrigues | ||||||||||
10/28/2021 | New | 247 | Commo | $25.00 | No | William | Warrant | Unrestrict | Section 4 | |
Issuance | n | Griswold | Exercise | ed | (a) (1) | |||||
10/15/2021 | New | 261 | Commo | $25.50 | No | OTA LLC / | Warrant | Unrestrict | Section 4 | |
Issuance | n | Ira M. | Exercise | ed | (a) (1) | |||||
Leventhal | ||||||||||
04/16/2021 | New | 5,500 | Commo | $11.02 | No | Westpark | Settlement | Restricte | Rule 506 | |
Issuance | n | Capital / | Agreement | d | (b) | |||||
Rick | ||||||||||
Rappaport | ||||||||||
04/08/2021 | Return to | (938) | Commo | $17.01 | No | Westpark | Settlement | NA | NA | |
Treasury | n | Capital / | Agreement | |||||||
Rick | ||||||||||
Rappaport | ||||||||||
03/25/2021 | New | 682 | Commo | $17.50 | No | Iroquois | Warrant | Unrestrict | Section 4 | |
Issuance | n | Master Fund | Exercise | ed | (a) (1) | |||||
OTC Markets Group Inc. | |
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021) | Page 4 of 12 |
/ Richard | |||||||||
Abbe | |||||||||
03/23/2021 | New | 170 | Commo | $24.00 | No | Iroquois | Warrant | Unrestrict | Section 4 |
Issuance | n | Capital | Exercise | ed | (a) (1) | ||||
Investment | |||||||||
Group / | |||||||||
Richard | |||||||||
Abbe | |||||||||
03/23/2021 | New | 20 | Commo | $24.00 | No | Charles | Warrant | Unrestrict | Section 4 |
Issuance | n | Merkel | Exercise | ed | (a) (1) | ||||
03/22/2021 | New | 2,359 | Commo | $22.76 | No | Brandon | Warrant | Unrestrict | Section 4 |
Issuance | n | Ross | Exercise | ed | (a) (1) | ||||
02/23/2021 | New | 2,151 | Commo | $7.13 | No | Rick | Warrant | Unrestrict | Section 4 |
Issuance | n | Rappaport | Exercise | ed | (a) (1) | ||||
02/23/2021 | New | 818 | Commo | $7.13 | No | Rick | Warrant | Unrestrict | Section 4 |
Issuance | n | Rappaport | Exercise | ed | (a) (1) | ||||
02/05/2021 | New | 1,797 | Commo | $5.85 | No | Brandon | Warrant | Unrestrict | Section 4 |
Issuance | n | Ross | Exercise | ed | (a) (1) | ||||
01/09/2020 | Re- | 1,047 | Commo | NA | NA | Various | Issued per | NA | NA |
issuance | common | n | roundup of | ||||||
shares | fractional | ||||||||
Issued | shares | ||||||||
reissued in | |||||||||
connection | |||||||||
with 160-1 | |||||||||
reverse split | |||||||||
Shares Outstanding on Date of This Report:
Ending Balance
Ending Balance:
Date 03/10/2022 | Common: 564,962 |
Preferred: 0
Example: A company with a fiscal year end of December 31st, in addressing this item for its quarter ended June 30, 2021, would include any events that resulted in changes to any class of its outstanding shares from the period beginning on January 1, 2019 through June 30, 2021 pursuant to the tabular format above.
Use the space below to provide any additional details, including footnotes to the table above:
OTC Markets Group Inc. | |
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021) | Page 5 of 12 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Tapinator Inc. published this content on 11 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 March 2022 13:19:04 UTC.